Author

Keith Ahamad

Observed names: Ahamad, Keith, K. Ahamad

Institutions: University of British Columbia, Asthma + Lung UK, British Columbia Centre on Substance Use

Observed institutions: University College Dublin, Providence Health Care, Vancouver Coastal Health, University of British Columbia, University of Ottawa, University of Toronto, St. Paul's Hospital, Asthma + Lung UK, British Columbia Centre on Substance Use, Centre Hospitalier de l’Université de Montréal, BC Centre for Excellence in HIV/AIDS, Université de Montréal

OpenAlex ID: A5070915003

Management of opioid use disorders: a national clinical practice guideline

2018 · Julie Bruneau, Keith Ahamad, et al. · Canadian Medical Association Journal · 412

PDF

Strategies to Identify Patient Risks of Prescription Opioid Addiction When Initiating Opioids for Pain

2019 · Jan Klimas, Lauren Gorfinkel, et al. · JAMA Network Open · 162

PDF

Will This Hospitalized Patient Develop Severe Alcohol Withdrawal Syndrome?

2018 · Evan Wood, Loai Albarqouni, et al. · JAMA · 114

Feasibility and safety of extended‐release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial

2017 · Philip T. Korthuis, Paula J. Lum, et al. · Addiction · 61

Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial

2022 · Didier Jutras-Aswad, Bernard Le Foll, et al. · American Journal of Psychiatry · 57

Dose–response relationship between methadone dose and adherence to antiretroviral therapy among HIV‐positive people who use illicit opioids

2015 · Leslie Lappalainen, Seonaid Nolan, et al. · Addiction · 53

Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort study

2015 · Keith Ahamad, Kanna Hayashi, et al. · The Lancet HIV · 48

The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale

2018 · M. Eugenia Socias, Keith Ahamad, et al. · Contemporary Clinical Trials · 37

Gender influences on initiation of injecting drug use

2014 · Keith Ahamad, Kora DeBeck, et al. · The American Journal of Drug and Alcohol Abuse · 31

PDF

Factors associated with willingness to take extended release naltrexone among injection drug users

2015 · Keith Ahamad, MJ Milloy, et al. · Addiction Science & Clinical Practice · 29

PDF

Building a hospital‐based addiction medicine consultation service in Vancouver, Canada: the path taken and lessons learned

2020 · Vivian Braithwaite, Lianping Ti, et al. · Addiction · 28

Factors associated with willingness to wear an electronic overdose detection device

2019 · Keith Ahamad, Huiru Dong, et al. · Addiction Science & Clinical Practice · 28

PDF

Two birds with one stone: experiences of combining clinical and research training in addiction medicine

2017 · J. Klimas, R. McNeil, et al. · BMC Medical Education · 28

PDF

Barriers and facilitators to implementing addiction medicine fellowships: a qualitative study with fellows, medical students, residents and preceptors

2017 · J. Klimas, W. Small, et al. · Addiction Science & Clinical Practice · 27

PDF

In-Hospital Training in Addiction Medicine: A Mixed-Methods Study of Health Care Provider Benefits and Differences

2019 · Lauren Gorfinkel, Jan Klimas, et al. · Substance Abuse · 25

PDF

Impact of a Brief Addiction Medicine Training Experience on Knowledge Self-Assessment among Medical Learners

2017 · Jan Klimas, Keith Ahamad, et al. · Substance Abuse · 25

An urgent call to increase access to evidence-based opioid agonist therapy for prescription opioid use disorders

2016 · M. Eugenia Socías, Keith Ahamad · Canadian Medical Association Journal · 24

PDF

The Impact of Benzodiazepine Use on Mortality among Polysubstance Users in Vancouver, Canada

2016 · Geoffrey R.T. Walton, Kanna Hayashi, et al. · Public Health Reports · 22

PDF

Impact of binge alcohol on mortality among people who inject drugs

2015 · Cheyenne Johnson, Huiru Dong, et al. · Addictive Behaviors Reports · 19

PDF

A Needs Assessment of the Number of Comprehensive Addiction Care Physicians Required in a Canadian Setting

2016 · Jasmine McEachern, Keith Ahamad, et al. · Journal of Addiction Medicine · 17

PDF

Increasing diversion of methadone in Vancouver, Canada, 2005–2015

2017 · Hudson Reddon, Joel Ho, et al. · Journal of Substance Abuse Treatment · 16

Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the OPTIMA study

2023 · Hamzah Bakouni, Christina McAnulty, et al. · American Journal on Addictions · 15

PDF

Successful Management of Gamma-hydroxybutyrate (GHB) Withdrawal Using Baclofen as a Standalone Therapy: A Case Report

2019 · Sonia Habibian, Keith Ahamad, et al. · Journal of Addiction Medicine · 14

Factors associated with willingness to participate in a pharmacologic addiction treatment clinical trial among people who use drugs

2015 · Sasha Uhlmann, Michael John Milloy, et al. · American Journal on Addictions · 12

PDF

Sustained release oral morphine as an alternative to methadone for the treatment of opioid-use disorder post Torsades de Pointes cardiac arrest